Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

7 digital health startups you need to watch in 2021

May 21, 2021 By Nancy Crotti

Cognito Therapeutics

Cognito Therapeutics devices

(Image courtesy of Cognito Therapeutics)

Cognito Therapeutics (Boston and San Francisco) won FDA breakthrough designation in January for its lead product, a non-invasive neurostimulation device that uses visual and auditory stimulation technology to treat Alzheimer’s disease and other neurodegenerative disorders.

The breakthrough program will give Cognito priority review and greater communication with the FDA about device development and clinical trial protocols, through to commercialization decisions.

MIT brain and cognitive sciences professors Li-Huei Tsai and Ed Boyden launched Cognito Therapeutics in 2016. The company recently reported the results of a pair of small clinical studies.

The Phase 2 Overture study enrolled 76 patients with mild to moderate Alzheimer’s disease, randomized to receive either gamma frequency neuromodulation or a placebo over a six-month period. Investigators evaluated cognitive and functional abilities and brain volumetric changes. Over the 6-month period, patients in the treatment group exhibited an 84% slowing of functional decline in scores on the ADCS-ADL Alzheimer’s Disease Cooperative Study–Activities of Daily Living Scale (ADCS-ADL) as well as an 83% slowing in memory and cognitive decline as measured by Mini-Mental State Exam (MMSE) scores compared to sham. Overture study investigators found that the treatment resulted in a 61% reduction in whole-brain atrophy and volumetric loss associated with Alzheimer’s progression.

The Phase 2 Flicker study assessed the safety and tolerability of the digital therapeutic in 10 patients with mild cognitive impairment due to Alzheimer’s. The study found that not only was the treatment safe and tolerable, but that the gamma frequency therapeutic intervention evoked the desired synchronous firing of brain cells across the brain, the company reported. That action stimulated changes in signaling molecules within the brain cells that led to changes in the cells’ immune profiles. The study also demonstrated improvements in functional connectivity between key brain regions, as shown by fMRI.

Cognito has also been on a hiring spree, just this month adding chief commercial officer Everett Crosland, who most recently served in the same role at Applied VR, and 30-year finance veteran Jonathan Lieber as CFO.

Dr. Allan Levey, professor and chairman of the Department of Neurology at Emory University and Director of the Emory Goizueta Alzheimer’s Disease Research Center, said in a news release that he is encouraged by Cognito’s approach. “This strategy translating recent advances in non-invasive modulation of brain activity with sensory stimulation with light and sound has the potential to be an urgently needed safe, non-invasive and effective treatment for millions of individuals with Alzheimer’s disease.”

Cognito declined to release its funding, but a spokesperson said its lead investor is Morningside Ventures.

Next>>

Pages: 1 2 3 4 5 6 7 8

Related Articles Read More >

This is a portrait photo of Kablooe Design CEO Tom Kramer
Kablooe Design CEO Tom KraMer taps veteran designer Fred Sklenar to steer firm
This is an Apple marketing image of mobility metrics in the Apple Health app in iOS 14.
Apple Health mobility data may hint at ortho surgery recovery
Edinburgh NeurEYE dementia screening with routine eye test (1)
AI-based software uses a routine eye test to predict dementia risk
This is a Mayo Clinic marketing image showing people interacting with Mayo Clinic Digital Pathology on a big computer display.
Mayo Clinic, Nvidia and Aignostics partner on digital pathology AI tools
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe